ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for pro Trade like a pro: Leverage real-time discussions and market-moving ideas to outperform.

PHAT Phathom Pharmaceuticals Inc

11.87
0.00 (0.00%)
Pre Market
Last Updated: 18:00:19
Delayed by 15 minutes
Share Name Share Symbol Market Stock Type
Phathom Pharmaceuticals Inc PHAT NASDAQ Common Stock
  Price Change Price Change % Share Price Last Trade
0.00 0.00% 11.87 18:00:19
Open Price Low Price High Price Close Price Previous Close
11.87
more quote information »

Recent News

Date Time Source Heading
15/6/202406:05EDGAR2Form 10-K/A - Annual report [Section 13 and 15(d), not S-K..
15/6/202406:05EDGAR2Form 10-Q/A - Quarterly report [Sections 13 or 15(d)]:..
07/6/202403:59EDGAR2Form SC 13D/A - General statement of acquisition of..
01/6/202408:34EDGAR2Form 4 - Statement of changes in beneficial ownership of..
28/5/202422:00GLOBEPhathom Pharmaceuticals to Participate in Upcoming Investor..
25/5/202409:46EDGAR2Form 4 - Statement of changes in beneficial ownership of..
25/5/202406:03EDGAR2Form 8-K - Current report
15/5/202422:00GLOBEPhathom Pharmaceuticals to Present VOQUEZNA® (vonoprazan)..
10/5/202406:06EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
09/5/202422:05EDGAR2Form 8-K - Current report
09/5/202422:00GLOBEPhathom Pharmaceuticals Reports First Quarter 2024 Financial..
29/4/202422:00GLOBEPhathom Pharmaceuticals to Report First Quarter 2024..
03/4/202423:00GLOBEPhathom Pharmaceuticals to Participate in the 23rd Annual..
26/3/202423:00GLOBEPhathom Pharmaceuticals Launches Direct-to-Consumer..
08/3/202408:01EDGAR2Form 10-K - Annual report [Section 13 and 15(d), not S-K..
08/3/202400:06EDGAR2Form 8-K - Current report
08/3/202400:00GLOBEPhathom Pharmaceuticals Reports Fourth Quarter and Full Year..
01/3/202400:00GLOBEPhathom Pharmaceuticals to Report Fourth Quarter and Full..
14/2/202400:05EDGAR2Form 8-K - Current report
14/2/202400:00GLOBEPhathom Pharmaceuticals Announces VOQUEZNA® (vonoprazan)..
01/2/202400:00GLOBEPhathom Pharmaceuticals to Present at the Guggenheim..
23/1/202412:21EDGAR2Form 4 - Statement of changes in beneficial ownership of..
16/12/202308:05EDGAR2Form 8-K - Current report
15/12/202300:05EDGAR2Form 8-K - Current report
15/12/202300:00GLOBEPhathom Pharmaceuticals Announces Expansion of Existing Loan..
07/12/202300:05EDGAR2Form 8-K - Current report
07/12/202300:00GLOBEPhathom Pharmaceuticals Announces FDA Acceptance for Filing..
29/11/202300:06EDGAR2Form 8-K - Current report
29/11/202300:00GLOBEPhathom Pharmaceuticals Announces Commercial Availability of..
20/11/202316:15EDGAR2Form EFFECT - Notice of Effectiveness
10/11/202308:02EDGAR2Form S-3 - Registration statement under Securities Act of..
10/11/202300:05EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
10/11/202300:05EDGAR2Form 8-K - Current report
10/11/202300:00GLOBEPhathom Pharmaceuticals Reports Third Quarter 2023 Results..
09/11/202311:56EDGAR2Form 4 - Statement of changes in beneficial ownership of..
04/11/202307:54EDGAR2Form 4 - Statement of changes in beneficial ownership of..
02/11/202308:50DJNPhathom Pharmaceuticals Gets FDA Approval for Voquezna..
02/11/202308:06EDGAR2Form 8-K - Current report
02/11/202308:00GLOBEPhathom Pharmaceuticals Announces FDA Approval of VOQUEZNA®..
30/10/202323:05EDGAR2Form 8-K - Current report
30/10/202323:00GLOBEPhathom Pharmaceuticals Announces FDA Approval of..
25/10/202323:01GLOBEPhathom Pharmaceuticals to Participate in Upcoming Investor..
26/9/202322:05EDGAR2Form 8-K - Current report
26/9/202322:01GLOBEPhathom Pharmaceuticals Announces Vonoprazan NDA Submission..
05/9/202322:00GLOBEPhathom Pharmaceuticals to Participate in Upcoming Investor..
21/8/202322:07EDGAR2Form 8-K - Current report
21/8/202322:00GLOBEPhathom Pharmaceuticals Announces Submission of Six-Month..
11/8/202306:02EDGAR2Form 8-K - Current report
10/8/202322:06EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
10/8/202322:01GLOBEPhathom Pharmaceuticals Reports Second Quarter 2023 Results

Your Recent History

Delayed Upgrade Clock